1 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J]. JAMA, 2016, 315(8):788-800.
|
2 |
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome [J]. N Engl J Med, 2010, 363(12):1107-1116.
|
3 |
Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome [J]. N Engl J Med, 2013, 368(23):2159-2168.
|
4 |
Maiolo G, Collino F, Vasques F, et al. Reclassifying acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2018, 197(12):1586-1595.
|
5 |
Madotto F, Pham T, Bellani G, et al. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study [J]. Intensive Care Med, 2018, 44(5):564-577.
|
6 |
Bos LD, Schouten LR, van Vught LA, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis [J]. Thorax, 2017, 72(10):876-883.
|
7 |
Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy [J]. Am J Respir Crit Care Med, 2017, 195(3):331-338.
|
8 |
Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial [J]. Lancet Respir Med, 2018, 6(9):691-698.
|
9 |
Gattinoni L, Carlesso E, Caironi P. Stress and strain within the lung [J]. Curr Opin Crit Care, 2012, 18(1):42-47.
|
10 |
Villar J, Martin-Rodriguez C, Dominguez-Berrot AM, et al. A quantile analysis of plateau and driving pressures: effects on mortality in patients with acute respiratory distress syndrome receiving lung-protective ventilation [J]. Crit Care Med, 2017, 45(5):843-850.
|
11 |
De Jong A, Cossic J, Verzilli D, et al. Impact of the driving pressure on mortality in obese and non-obese ARDS patients: a retrospective study of 362 cases [J]. Intensive Care Med, 2018, 44(7):1106-1114.
|
12 |
Schmidt MFS, Amaral A, Fan E, et al. Driving pressure and hospital mortality in patients without ARDS: a cohort study [J]. Chest, 2018, 153(1):46-54.
|
13 |
Blondonnet R, Joubert E, Godet T, et al. Driving pressure and acute respiratory distress syndrome in critically ill patients [J]. Respirology, 2019, 24(2):137-145.
|
14 |
Toufen Junior C, De Santis Santiago RR, Hirota AS, et al. Driving pressure and long-term outcomes in moderate/severe acute respiratory distress syndrome [J]. Ann Intensive Care, 2018, 8(1):119.
|
15 |
Goligher EC, Dres M, Fan E, et al. Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes [J]. Am J Respir Crit Care Med, 2018, 197(2):204-213.
|
16 |
Schepens T, Dres M, Heunks L, et al. Diaphragm-protective mechanical ventilation [J]. Curr Opin Crit Care, 2019, 25(1):77-85.
|
17 |
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure [J]. N Engl J Med, 2015, 372(23):2185-2196.
|
18 |
Azoulay E, Lemiale V, Mokart D, et al. Effect of high-flow nasal oxygen vs standard oxygen on, 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial [J]. JAMA, 2018, 320(20):2099-2107.
|